Magenta Therapeutics, Inc. Gains 32.2%
Wed, May 18, 2022 at 05:30 PM
Magenta Therapeutics, Inc. (MGTA:NASDAQ) jumped higher at $1.56, a gain of 32.2%. The stock got featured on our News Catalysts scanner on Mon, May 16, 2022 at 04:55 PM in the 'BIOTECH' category. From Wed, May 04, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
About Magenta Therapeutics, Inc. (MGTA:NASDAQ)
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.
Top 10 Gainers:
- Bright Green Corporation (BGXX:NASDAQ), 90.45%
- Troika Media Group Inc. (TRKA:NASDAQ), 52.07%
- Armstrong Flooring, Inc. (AFI:NYSE), 45.96%
- Magenta Therapeutics, Inc. (MGTA:NASDAQ), 32.2%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- RiceBran Technologies (RIBT:NASDAQ), 22.08%
- Sunlands Technology Group (STG:NYSE), 21.83%
- BigBear.ai Inc. (BBAI:NYSE), 21.18%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 20.62%
- Cabot Oil & Gas Corporation (COG:NYSE), 20.08%